Bioptic Company (@BiopticIO) — Twitter Score 7 out of 1000

Bioptic Company is an AI-driven drug-discovery company that pivoted from NFT authentication infrastructure to biopharma automation in August 2023, now operating as BIOPTIC. Bioptic Company's Twitter Score is 7.2 out of 1000 as of October 2026, ranking #123,420 among 493,668 tracked accounts.

Bioptic Company was originally launched as Optic, Inc., an AI-powered engine built to authenticate NFTs by detecting visual similarities such as image flips and color changes. During its Web3 phase, the platform processed 2TB of newly submitted NFTs per day across its cross-chain content-recognition system, and OpenSea selected its Marketplace Moderation Tool to help detect copied NFTs. The company reported that within its first year it had identified more than 67 million counterfeit NFTs across nine blockchains, achieving detection speeds below 500 milliseconds. The company was co-founded by Andrey Doronichev, Vlad Vinogradov, and Roman Doronin.

Bioptic Company raised an $11 million seed round announced on July 20, 2022, co-led by Kleiner Perkins and Pantera Capital, with additional backing from Greylock Partners, Lattice Capital, OpenSea, Circle, Polygon, CoinDCX, Neon DAO, and Flamingo DAO.

Bioptic Company now operates a platform of vertical AI agents for biopharma that automate drug-asset discovery, diligence, and in-licensing. In October 2024, the company entered a strategic partnership with eMolecules, integrating a chemical library of more than 20 million compounds into its AI platform. BIOPTIC researchers have also published a target-agnostic molecular-search system reported to screen the 40-billion-compound Enamine REAL library with 100% recall. Bioptic Company has published 221 posts on the platform.

Who follows Bioptic Company on X?

The accounts that follow Bioptic Company include 27 founders, 10 angel investors, 18 influencers and 1 VCs, among them OpenSea, Jane Spencer, Andrew Steinwold, Regan Bozman, paul.nft and Minion.